Pirfenidone Tablet, Coated
Product Images NDC 76282-717

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 76282-717). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pirfenidone Figure1)

A cumulative distribution curve chart comparing the percentage of patients experiencing absolute change in %FVC from baseline to week 52 for Pirfenidone versus placebo. The x-axis shows the absolute change in %FVC, ranging from -30% to +10%, with the y-axis representing the cumulative percentage of patients. The chart highlights worsening (decrease in %FVC) and no decline (increase in %FVC) regions, with distinct curves for Pirfenidone (solid line) and placebo (dotted line) groups.*

FDA Label Image

Figure 2 (Pirfenidone Figure2)

A line graph showing mean change in Forced Vital Capacity (FVC) in mL over 52 weeks. The graph compares Pirfenidone (solid line, n=278) with placebo (dashed line, n=277), illustrating a smaller decline in FVC for the Pirfenidone group across the study period.*

FDA Label Image

Figure 3 (Pirfenidone Figure3)

A survival curve graph showing the percentage of patients alive over time in weeks, comparing Pirfenidone and placebo groups. The graph includes number of patients at risk at different time points and a hazard ratio with confidence interval comparing the two groups.*

FDA Label Image

801 mg (Pirfenidone Pdp 1)

Label for Pirfenidone Tablets, 801 mg film-coated oral tablets. The label shows the product name, strength, and quantity of 90 tablets. It includes storage instructions and manufacturing details for Exelan Pharmaceuticals, Inc. and ScieGen Pharmaceuticals, Inc. The label also features a barcode and states 'Rx Only.'*

FDA Label Image

801 mg (Pirfenidone Pdp 2)

Pirfenidone Tablets 801 mg coated tablets label showing the product name, strength, and quantity of 270 tablets. The label includes storage instructions, manufacturing details by ScieGen Pharmaceuticals, Inc., and the labeler as Exelan Pharmaceuticals, Inc. The label product code is NDC 76282-716-27, and it is marked Rx Only.*

FDA Label Image

267 mg (Pirfenidone Pdp 5)

Pirfenidone Tablets 267 mg film-coated oral tablets in a 90-tablet package by Exelan Pharmaceuticals Inc. The label includes storage instructions and manufacturing details.*

FDA Label Image

267 mg (Pirfenidone Pdp 6)

Label for Pirfenidone Tablets, 267 mg coated oral tablets, by Exelan Pharmaceuticals Inc. The label includes NDC 76282-717-27, a quantity of 270 tablets, and storage instructions at 25°C with permitted excursions. Manufactured for Exelan Pharmaceuticals and by ScieGen Pharmaceuticals.*

FDA Label Image

Pirfenidone (Pirfenidone Structure)

Chemical structure diagram of the active ingredient Pirfenidone, showing the arrangement of benzene rings and functional groups characteristic of this compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.